Abstract
Transdermal drug delivery system was first introduced more than 30 years ago. The technology generated tremendous excitement and interest amongst major pharmaceutical companies in the 1980s and 90s. By the mid to late 1990s, the trend of transdermal drug delivery system merged into larger organizations. Ethosomes are the ethanolic phospholipid vesicles which are used mainly for transdermal delivery of drugs. Ethosomes have higher penetration rate through the skin as compared to liposomes hence these can be used widely in place of liposomes. Ethosomes have become an area of research interest, because of its enhanced skin permeation, improved drug delivery, increased drug entrapment efficiency etc. The purpose of writing this review on ethosomes drug delivery was to compile the focus on the various aspects of ethosomes including their mechanism of penetration, preparation, advantages, composition, characterization, application and marketed product of ethosomes. Characterizations of ethosomes include Particle size, Zeta potential, Differential Scanning Calorimertry, Entrapment efficiency, Surface tension activity measurement, Vesicle stability and Penetration Studies etc.
References
Gangwar S, Singh S, Garg G, “Ethosomes: A novel tool for drug delivery through the skin”, Journal of Pharmacy Research 2010, 3 (4), 688-691.
Kumar KP, Radhika PR, Sivakumar T, “Ethosomes-A Priority in Transdermal Drug Delivery”, International Journal of Advances in Pharmaceutical Sciences, 2010, 1, 111-121.
Heeremans JLM, Gerristen HR, Meusen SP, Mijnheer FW, Gangaram RS, Panday G, Prevost R, Kluft C, Crommelin DJA, “The preparation of tissue type plasminogen activator (t- PA) containing liposomes: entrapment efficacy and ultracentrifugation damage”, J Drug Target, 1995, 3, 301.
Asbill CS, El-Kattan AF, Michniak B, “Enhancement of transdermal drug delivery: chemical and physical approaches”, Crit Rev Therapeut Drug Carrier Sys, 2000, 17, 621.
Touitou E, Dayan N, Levi-Schaffer F, Piliponsky A, “Novel lipid vesicular system for enhanced delivery”, J Lip Res, 1998, 8, 113.
Verma P, Pathak K, “Therapeutic and cosmeceutical potential of ethosomes: An overview”, J Adv Pharm Tech Res, 2010, 1, 274-82.
Jain S, Umamaheshwari RB, Bhadra D, Jain NK, “Ethosomes: a novel vesicular carrier for enhanced transdermal delivery of an anti-HIV agent”, Ind J Pharma Sci, 2004, 66, 72-81.
Touitou E, Godin B, Dayan N, Weiss C, Piliponsky A, Levi-Schaffer F, “Intracellular delivery mediated by an ethosomal carrier”, Biomaterials, 2001, 22, 3053-3059.
Bhalaria MK, Naik S, Misra AN, “Ethosomes: A novel delivery system for antifungal drugs in the treatment of topical fungal diseases”, Indian Journal of Experimental Biology 2009, 47, 368-375.
Verma DD, Fahr A, “Synergistic penetration effect of ethanol and phospholipids on the topical delivery of Cyclosporin A”, J. Control Release, 2004, 97, 55-66.
Nikalje AP, Tiwari S, “Ethosomes: A Novel Tool for Transdermal Drug Delivery”, IJRPS, 2012, 2 (1), 1-20.
Dinesh D, Amit AR, Maria S, Awaroop R L, Mohd HGD, “Drug vehicle based approaches of penetration enhancement”, Int. J. Pharm. Pharm. Sci., 2009, 1 (1), 24-45.
Maghraby GM, Williams AC, Barry BW, “Oestradiol skin delivery from ultra deformable liposomes: refinement of surfactant concentration” Int. J. Pharma., 2000, 63-74.
Cevc G, Schatzlein A, Blume G, “Transdermal drug carriers: Basic properties, optimization and transfer efficiency in case of epicutaneously applied peptides”, J. Cont. Release, 1995, 36, 3-16.
Fry DW, White JC, Goldman ID, “Rapid secretion of low molecular weight solutes 1from liposomes without dilution”, Analytical Biochemistry 1978, 90, 809-815.
Lopez-Pinto JM, Gonzalez-Rodriguez ML, Rabasco AM, “Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes”, Int. J. Pharma., 2005, 298, 1-12.
Touitou E, “Composition of applying active substance to or through the skin”, US Patent: 5716638, 1996.
Touitou E, “Composition of applying active substance to or through the skin”, US Patent: 5540934, 1998.
Anitha PS, Ramkanth K, Sankari UM, Alagusundaram K, Gnanapraksah P, Devaki DR, Indira P, “Ethosomes - A noninvasive vesicular carrier for transdermal drug delivery”, Int. J. Rev. Life. Sci., 2011, 1 (1), 17-24.
Kim S, Chien YW, “Toxicity of cationic lipids and cationic polymers in gene delivery”, J. Control. Release, 1996, 40, 67-76.
Spruance SL, Semin, “The natural history of recurrent oral facial herpes simplex virus infec tion”, Dermatol, 1992, 11, 200-206.
Fiddan AP, Yeo JM, Strubbings R, Dean D, “Vesicular Approach for Drug Delivery into or Across the Skin”, Br. Med. J., 1983, 286, 1699.
Fang J, Hong C, Chiu W, Wang Y, “Effect of liposomes and niosomes on skin permeation of enoxacin”, Int. J. Pharm., 2001, 219, 61-72.
Johnsen SG, Bennett EP, Jensen, VG Lance, “Therapeutic effectiveness of oral testosterone” 1974, 2, 1473-1475.
Chetty DJ, Chien YW, “Transdermal Delivery of CaCO3-Nanoparticles Containing Insulin”, Crit Rev Ther Drug Carrier Syst., 1998, 15, 629-670.
Verma DD, Fahr A, “Synergistic penetration effect of ethanol and phospholipids on the topical delivery of Cyclosporin A”, J. Control Release, 2004, 97, 55-66.
Paolino D, Lucania G, Mardente D, Alhaique F, Fresta M, “Innovative Drug Delivery Systems for the Administration of Natural Compounds”, J. Control. Release, 2005, 106, 99-110.
Fu Y, Hsieh J, Guo J, Kunicki J, Lee MY, Darzynkiewicz Z, Wu JM, Licochalcone A, “Anti-inflammatory efficacy of Licochalcone A: correlation of clinical potency and in vitro effects”, Biochem. Biophys. Res. Commun., 2004, 322, 263-270.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyright (c) 2020 Array